Miaomiao Niu

14PUBLICATIONS
14CO-AUTHORS
Characterisation of biological macromoleculesMolecular targetsBiomaterialsClinical pharmacology and therapeuticsNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 13, 2026
Discovery of the First Highly Potent and Selective Peptide Inhibitor Targeting Microtubule-MAP7 Interaction via Structure-Based Design for Suppressing Colorectal Cancer Cell Proliferation.

|Feb 25, 2026
Discovery of a Novel Dual-Targeting KRASG12D/HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer.

Qiaoxuan Zhang, Yifei Geng, Haitao Chen

|Apr 10, 2025
Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions.

Kaicheng Tang, Zhongjie Tang, Miaomiao Niu

|Apr 17, 2024
Discovery of a Potent Dual Son of Sevenless 1 (SOS1) and Epidermal Growth Factor Receptor (EGFR) Inhibitor for the Treatment of Prostate Cancer.

Lufeng Zheng, Yuxin Zhang, Shuang Mei

|Dec 14, 2023
Discovery of a Dual Tubulin and Neuropilin-1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation.

Lufeng Zheng, Yunting Zou, Tianyuan Xie

|Nov 22, 2022
Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization.

Yin Yuan, Hong Yao, Manzhen Zhou

Pageof 3

Frequent Collaborators

4 joint publications

Lufeng Zheng

2 joint publications

Chong Li

1 joint publications

Bin Di

1 joint publications

Pierre Dramou